Jin Yang Pharmaceutical Co. Ltd - Asset Resilience Ratio

Latest as of March 2026: 1.23%

Jin Yang Pharmaceutical Co. Ltd (007370) has an Asset Resilience Ratio of 1.23% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jin Yang Pharmaceutical Co. Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩3.35 Billion

≈ $2.27 Million USD Cash + Short-term Investments

Total Assets

₩271.49 Billion

≈ $183.99 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Jin Yang Pharmaceutical Co. Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Jin Yang Pharmaceutical Co. Ltd (007370) total assets.

Liquid Assets Composition Over Time

This chart breaks down Jin Yang Pharmaceutical Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Jin Yang Pharmaceutical Co. Ltd (007370) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩3.35 Billion	1.23%
Total Liquid Assets	₩3.35 Billion	1.23%

Asset Resilience Insights

Limited Liquidity: Jin Yang Pharmaceutical Co. Ltd maintains only 1.23% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jin Yang Pharmaceutical Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Jin Yang Pharmaceutical Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Jin Yang Pharmaceutical Co. Ltd (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Jin Yang Pharmaceutical Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.38%	₩3.68 Billion ≈ $2.50 Million	₩267.81 Billion ≈ $181.49 Million	+0.49pp
2024-12-31	0.88%	₩2.01 Billion ≈ $1.36 Million	₩227.57 Billion ≈ $154.22 Million	-6.28pp
2023-12-31	7.17%	₩8.60 Billion ≈ $5.82 Million	₩119.91 Billion ≈ $81.26 Million	-2.00pp
2022-12-31	9.17%	₩10.49 Billion ≈ $7.11 Million	₩114.44 Billion ≈ $77.56 Million	-5.93pp
2021-12-31	15.10%	₩14.87 Billion ≈ $10.08 Million	₩98.50 Billion ≈ $66.75 Million	+7.28pp
2020-12-31	7.82%	₩5.33 Billion ≈ $3.61 Million	₩68.08 Billion ≈ $46.13 Million	+0.75pp
2019-12-31	7.07%	₩4.83 Billion ≈ $3.27 Million	₩68.28 Billion ≈ $46.27 Million	+3.81pp
2018-12-31	3.26%	₩2.29 Billion ≈ $1.55 Million	₩70.06 Billion ≈ $47.48 Million	+1.22pp
2017-12-31	2.04%	₩1.51 Billion ≈ $1.02 Million	₩73.85 Billion ≈ $50.05 Million	+1.07pp
2016-12-31	0.97%	₩746.86 Million ≈ $506.14K	₩76.78 Billion ≈ $52.04 Million	-1.33pp
2015-12-31	2.30%	₩2.00 Billion ≈ $1.36 Million	₩86.90 Billion ≈ $58.89 Million	-5.52pp
2014-12-31	7.82%	₩6.00 Billion ≈ $4.07 Million	₩76.68 Billion ≈ $51.97 Million	--

pp = percentage points

About Jin Yang Pharmaceutical Co. Ltd

KQ:007370 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$38.32 Million

₩56.54 Billion KRW

Market Cap Rank

#22970 Global

#1523 in Korea

Share Price

₩4000.00

Change (1 day)

+0.63%

52-Week Range

₩3440.00 - ₩5980.00

All Time High

₩9262.22